Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance
Go back to Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.60 | 52 Week High | $21.49 | |||
| Open | $5.60 | 52 Week Low | $15.75 | |||
| Day High | $5.60 | P/E | 6.36 | |||
| Day Low | $5.60 | EPS | $0.88 | |||
| Volume | 18,867 | |||||
